Bluejay Diagnostics, Inc. (BJDX)
NASDAQ: BJDX · Real-Time Price · USD
1.000
-0.030 (-2.91%)
Sep 9, 2026, 3:33 PM EDT - Market open
Bluejay Diagnostics Market Cap
Bluejay Diagnostics has a market cap or net worth of $4.47 million as of September 9, 2026. Its market cap has increased by 110.58% in one year.
Market Cap
4.47M
Enterprise Value
-5.05M
1-Year Change
110.58%
Ranking
Category
Stock Price
$1.00
ChartMarket Cap Chart
Since the IPO on November 10, 2021, Bluejay Diagnostics's market cap has decreased from $67.42M to $4.47M, a decrease of -93.37%. That is a compound annual growth rate of -42.97%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 9, 2026 | 4.47M | 269.14% |
| Dec 31, 2025 | 1.21M | -55.01% |
| Dec 31, 2024 | 2.69M | 78.09% |
| Dec 29, 2023 | 1.51M | -80.24% |
| Dec 30, 2022 | 7.65M | -84.67% |
| Dec 31, 2021 | 49.89M | -26.00% |
| Nov 10, 2021 | 67.42M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Phaos Technology Holdings (Cayman) Limited | 5.20M |
| WORK Medical Technology Group LTD | 5.08M |
| VolitionRx | 4.97M |
| Autonomix Medical | 4.46M |
| Vivos Therapeutics | 3.75M |
| ENvue Medical | 3.72M |
| Nexalin Technology | 3.72M |
| Beyond Air | 3.38M |